PubMed ID: 40349981 Author(s): Uner OE, Lin P, Kopplin LJ, Lum F, Liu L, Li C, Arepalli S, Goldstein D, Rosenbaum JT, Suhler EB, Thomas AS. Prevalence, Treatment Patterns, and Outcomes of Pediatric Non-Infectious Uveitis …
Laura Kopplin
CLARITY
A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis
Manifestations and Management of Inflammatory Eye Disease in Patients with Inflammatory Bowel Disease.
PubMed ID: 38848110 Author(s): Arzbecker M, Kopplin LJ. Manifestations and Management of Inflammatory Eye Disease in Patients with Inflammatory Bowel Disease. Ocul Immunol Inflamm. 2024 Dec;32(10):2348-2353. doi: 10.1080/09273948.2024.2362881. Epub 2024 Jun 7. PMID 38848110 Journal: …
Therapeutic Outcomes of Non-Infectious Scleritis Treated with Tumor Necrosis Factor-Alpha Inhibitors.
PubMed ID: 37043601 Author(s): Brown JE, Thomas AS, Armbrust KR, Boyd K, Berkenstock M, Kopplin LJ. Therapeutic Outcomes of Non-Infectious Scleritis Treated with Tumor Necrosis Factor-Alpha Inhibitors. Ocul Immunol Inflamm. 2024 Aug;32(6):1017-1023. doi: 10.1080/09273948.2023.2191712. Epub …
Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR.
PubMed ID: 39029105 Author(s): Elwood KF, Warner EJ, Chang JS, Kopplin LJ. Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR. Retin Cases Brief Rep. 2024 Jul 19. doi: 10.1097/ICB.0000000000001633. Online ahead of print. …
Risk Factors Associated with Unexpected Refractive Outcomes in Uveitic Cataract Surgery.
PubMed ID: 36931285 Author(s): Lee DJ, Seto S, Banghart M, Boyd K, Thuruthumaly C, Suhler EB, Kopplin LJ. Risk Factors Associated with Unexpected Refractive Outcomes in Uveitic Cataract Surgery. Ocul Immunol Inflamm. 2024 Jul;32(5):642-647. doi: …
SANDCAT
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema (Sandcat)
IZOKIBEP (IL-17A)
To assess the safety, tolerability, and immunogenicity of izokibep in subjects with active non-infectious, intermediate-, posterior- or pan-uveitis requiring high-dose steroids.
Characteristics and Outcomes of Patients with Scleritis in the IRIS® Registry (Intelligent Research in Sight) Database.
PubMed ID: 36245751 Author(s): Armbrust KR, Kopplin LJ. Characteristics and outcomes of patients with ccleritis in the IRIS® registry (Intelligent Research in Sight) database. Ophthalmol Sci. 2022 Jun 4;2(3):100178. doi: 10.1016/j.xops.2022.100178. eCollection 2022 Sep. PMID …